Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update

SAN DIEGO, CA and TAICANG, China, April 16, 2024 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma,” “Connect” or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research, today reported financial results for the year ended December 31, 2023, and provided a business update.

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks